BTA peaked at $7.03 on 30 Dec 1999 and shortly thereafter plunged to a low of $0.37 on 30 Sept 2000.
It is interesting to see this level of trading ahead of the 22 April GSK release of the Relenza sale figure.
Aliron was selling as notified in the change in substantial holding notice last week 24/03/09. Are they selling down ahead of the GSK result?